Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation

Journal of Bone and Mineral Research

Volumn 14, Issue 3, 1999, Pages 342-350

  Ebeling, Peter R ^a   Thomas, David M ^a   Erbas, Bircan ^a   Hopper, John L ^a   Szer, Jeffrey ^a   Grigg, Andrew P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOTRANSPLANTATION; AVASCULAR NECROSIS; BONE ATROPHY; BONE TURNOVER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; MALE;

EID: 0032971518     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.3.342     Document Type: Article

References (30)

1. Katz IA, Epstein S 1992 Posttransplantation Bone disease. J Bone Miner Res 7:123-126.
2. Carlson K, Simonsson B, Ljunghall S 1994 Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcif Tissue Int 55:408-411.
3. Kelly PJ, Atkinson K, Ward RL, Sambrook PN, Biggs JC, Eisman JA 1990 Reduced bone mineral density in men and women with allogeneic bone marrow transplantation. Transplantation 50:881-883.
4. Chatterjee R, Goldstone AH 1996 Gonadal damage and effects on fertility in adult patients with haematological malignancy undergoing stem cell transplantation. Bone Marrow Transplant 17:5-11.
5. Spinelli S, Chiodi S, Bacigalupo A, Brasca A, Menada MV, Petti AR, Ravera G, Gualandi F, VanLint MT, Sessarego M, Frassoni F, Occini D, Lamparelli T, Valeriani A, Oneto R, Vitale V, Corvo R, Marmount AM 1994 Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: Long-term follow up of 79 females. Bone Marrow Transplant 14:373-380.
6. Shalet SM, Didi M, Ogilvy-Stuart AL, Schulga J, Donaldson MDC 1995 Growth and endocrine function after bone marrow transplantation. Clin Endocrinol (Oxf) 42:333-339.
7. Chatterjee R, Mills W, Katz M, McGarrigle HH, Goldstone AH 1994 Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogeneic marrow transplantation in post-menarcheal female patients. Bone Marrow Transplant 13:511-517.
8. Stern JM, Chesnut CH III, Bruemmer B, Sullivan KM, Lenssen PS, Aker SN, Sanders J 1996 Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant 17:395-400.
9. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S 1988 Cyclosporin-A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration. Endocrinology 123:2571-2577.
10. Withold W, Wolf HH, Kollbach S, Heyll A, Schneider W, Reinauer H 1996 Relationship between bone metabolism and plasma cytokine levels in patients at risk of post-transplantation bone disease after bone marrow transplantation. Eur J Clin Chem Clin Biochem 34:295-299.
11. Hamanishi C, Yoshii T, Totani Y, Tanaka S 1994 Bone mineral density of lengthened rabbit tibia is enhanced by transplantation of fresh autologous bone marrow cells. Clin Orthop 303:250-255.
12. Fung H, Barnett M, Klingemann H, Shepherd J, Nantel S, Sutherland H 1994 Delayed complications of volunteer unrelated donor bone marrow transplantation (VUD-BMT). Blood 84 (Suppl 1):A1954 (abstract).
13. Abraham R, Szer J, Bardy P, Grigg A 1997 Early cyclosporin taper in high risk sibling allogeneic bone marrow transplants. Bone Marrow Transplant 20:773-777.
14. Eyre DR, Koob TJ, Van Ness KP 1984 Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 137:380-388.
15. Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, Wark JD 1996 Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 81:3366-3371.
16. Garnero P, Delmas PD 1993 Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 77:1046-1053.
17. Khan KM, Henzell SL, Broderick C, Prince RL, Saul A, Lomman J, Wark JD 1997 Instrument performance in bone density testing at five Australian centres. Aust N Z J Med 27:526-530.
18. McCullagh P, Nelder JA 1989 Generalized linear models. Monographs on Statistics and Applied Probability, 2nd Ed, No 37. Chapman and Hall, London, U.K.
19. Shane E, Rivas MC, Silverberg SJ, Kim TS, Staron RB, Bilezikian JP 1993 Osteoporosis after cardiac transplantation. Am J Med 94:257-264.
20. Sambrook PN, Kelly PJ, Fontana D, Nguyen T, Keogh A, Macdonald P, Spratt P, Freund J, Eisman JA 1994 Mechanisms of rapid bone loss following cardiac transplantation. Osteoporos Int 4:273-276.
21. Atkinson K, Nivison-Smith I, Hawkins T 1997 Haemopoietic stem cell transplantation in Australia, 1992-95: A report from the Australian Bone Marrow Transplant Recipient Registry. Aust N Z J Med 27:408-419.
22. Enright H, Haake R, Weisdorf D 1990 Avascular necrosis of bone: A common serious complication of allogeneic bone transplantation. Am J Med 89:733-738.
23. Muchmore JS, Cooper DKC, Ye Y, Schlegel VT, Zuhdi N 1991 Loss of vertebral bone density in heart transplant patients. Transplant Proc 23:1184-1185.
24. Shane E, Thys-Jacobs S, Papadopopoulos A, Addesso V, Mancini D, Seibel MJ, Silverberg SJ, Staron RB 1996 Antiresorptive therapy prevents bone loss after cardiac transplantation (CTX). J Bone Miner Res 11 (Suppl 1):S340 (abstract).
25. Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste.-Marie L-G, Tenenhouse A, Chines AA 1997 Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 337:382-387.
26. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG 1998 Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis: Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339:292-299.
27. Sambrook P, Marshall G, Henderson K, Keogh A, MacDonald P, Spratt P, Ebeling P, Eisman J 1997 Effect of calcitriol in the prevention of bone loss after cardiac or lung transplantation. J Bone Miner Res 12 (Suppl 1):S400 (abstract).
28. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman J 1993 Prevention of corticosteroid osteoporosis: A comparison calcium, calcitriol calcitonin. N Engl J Med 328:1747-1752.
29. Prior JC, Vigna YM, Wark JD, Eyre DR, Lentle BC, Li DKB, Ebeling PR, Alley L 1997 Premenopausal ovariectomy-related bone loss: A randomised, double-blind one year trial of conjugated estrogen or medroxyprogesterone acetate. J Bone Miner Res 12:1851-1863.
30. Castelo-Branco C, Rovira M, Pons F, Duran M, Sierra J, Vives A, Balasch J, Fortuny A, Vanrell J 1996 The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation. Maturitas 23:307-312.